Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I am still looking for an Open "Letter to all Stockholders" by the company

Hopefully this type of direct communication will come this week, either contemporaneously or on the heels of the Q release.

Shareholders have had no Open Letter update communications about the state of our company by our CEO since August 2011; when they reiterated "significant developments with PDSG, and cautious optimism..", and that "reaching a fair settlement with TPL is unlikely, and that the interests of Patriot and it's Stockholders will be best achieved through litigation"

"Patriot Scientific Corporation Provides Update" http://patriotscientific.com/index.php?option=com_content&task=view&id=276&Itemid=29

I await an Open Letter to Shareholders, it's been two years. Press release "blurbs" are very different than a CEO communication; and there is much Cliff should and can address.

Share
New Message
Please login to post a reply